By  on February 21, 2017
The ADNAS lab

Applied DNA Sciences has significantly expanded its U.S. and global patent portfolio, demonstrating its ongoing commitment to innovation in biotechnology-driven solutions to help protect the textile supply chain from theft, counterfeiting, fraud and diversion.

Applied DNA’s U.S. and global patent portfolio now totals 44 issued patents, with 84 applications pending. In 2016, Applied DNA was granted new patents in broad, long-term protection for its core business verticals, including its FiberTyping, SigNature DNA, SigNature T and BackTrack platforms, as well as its bulk DNA production services.

To Read the Full Article

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus